Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach
- 1 August 2024
- journal article
- review article
- Published by Springer Nature in International Journal of Hematology
- Vol. 120 (3) , 271-277
Abstract
Thalassemia is an inherited genetic disorder of hemoglobin that affects a large population worldwide, and it is estimated that between 50,000 and 60,000 infants with thalassemia are born each year. The most common treatment for thalassemia is blood transfusion, which leads to iron overload. This in itself is a serious clinical condition, and is commonly managed with iron chelation therapy. However, iron chelators can cause various skin complications, including hyperpigmentation, skin rash, itching, and photosensitivity. These skin side effects can impact patients’ quality of life. Therefore, this article provides a comprehensive overview of skin complications caused by iron chelators, along with a proposed comprehensive approach to their management in patients with beta-thalassemia. Key strategies include patient education, regular skin assessment, sun protection measures, symptomatic relief with topical corticosteroids and antihistamines, and consideration of treatment modification if severe complications occur. Collaboration between hematologists and dermatologists, along with psychological support and regular follow-up, is an essential component of this multidisciplinary approach. By implementing these strategies, healthcare providers can optimize skin care for patients with beta-thalassemia treated with iron chelators and improve their quality of life.Keywords
Funding Information
- Ilam University of Medical Sciences
This publication has 71 references indexed in Scilit:
- TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron HomeostasisAdvances in Therapy, 2023
- Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteersAmerican Journal of Hematology, 2019
- Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical EvidencePhytotherapy Research, 2016
- Thiol-derivatized minihepcidins retain biological activityBioorganic & Medicinal Chemistry Letters, 2015
- Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agentNanomedicine: Nanotechnology, Biology and Medicine, 2015
- Successful treatment of hydroxyurea-associ ated chronic leg ulcers associated with squamous cell carcinomaHematology/Oncology and Stem Cell Therapy, 2014
- Hydroxyurea in Sickle Cell Disease: Drug ReviewIndian Journal of Hematology and Blood Transfusion, 2013
- Efficacy and safety of deferasirox in myelodysplastic syndromesAnnals of Hematology, 2013
- Iron chelation therapy in the management of thalassemia: the Asian perspectivesInternational Journal of Hematology, 2009
- Cutaneous reactions to imatinib mesylate treated by topical steroidAmerican Journal of Hematology, 2005